(BTX:Consolidated issues listed on NYSE MKT LLC)
Thomas B. Okarma M.D., Ph.D.
Former Chief Executive Officer of Biotime Acquisition Corp. and Director of Biotime Acquisition Corp., BioTime, Inc.
|Age||Total Calculated Compensation||This person is connected to 98 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Dr. Thomas B. Okarma, M.D., Ph.D. served as the Chief Executive Officer of Asterias Biotherapeutics, Inc. from September 2012 to April 10, 2014 and also served as its President until April 10, 2014. Dr. Okarma served as the Chief Executive Officer of BioTime Acquisition Corp. since October 2012. He served as the Chief Executive Officer and President of Geron Corporation from July 1999 to February 9, 2011 and also served as its President of Oncology from January 2008 ...
1301 Harbor Bay ParkwayPhone: 510-521-3390
Alameda, California 94502
Board Members Memberships*
Former Chief Executive Officer, President, Director, Member of Stock Option Committee and Director of Geron Bio-Med Limited
Former Chief Executive Officer, President and Director
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|John A. Scarlett M.D.||Chief Executive Officer, President and Director|
|David M. Pernock||Chairman of the Board, Chief Executive Officer and President|
Fibrocell Science, Inc.
|Paul K. Wotton Ph.D.||Chief Executive Officer, President, Director and Member of Pricing Committee|
Ocata Therapeutics, Inc.
|Yokoyama Chikafumi Ph.D.||Chief Executive Officer, President and Representative Director|
|Keith Murphy||Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee|
Organovo Holdings, Inc.
|$362.9K||Compensation as of Fiscal Year 2014.|